As countries across the world debate reopening of schools, a new study has found that children younger than five years with mild to moderate COVID-19 have much higher levels of the novel coronavirus genetic material in the nose compared to older children and adults.
The findings, published in the journal JAMA Pediatrics, shed light on the possibility that the youngest children transmit the virus as much as other age groups.
You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.
Here are the latest updates:
9.50 am | India
Over 57,000 new cases in the past 24 hours
India has again registered a record single-day jump of 57,118 cases in the past 24 hours, pushing India’s total COVID-19 tally to 16,95,988, the Union Health Ministry said in its daily bulletin early on Saturday.
The total death toll is now 36,511, with 764 new fatalities, it added.
The active COVID-19 case count stands at 5,65,103, while 10,94,374 people have recovered so far, according to the Union Health Ministry.
9.20 am | Noida
Prohibitory orders extended in Gautam Buddh Nagar till Aug 31
Restrictions under Section 144 of the Criminal Procedure Code (CrPC), which bars assembly of more than four people, have been extended till August 31 in Uttar Pradesh’s Gautam Buddh Nagar district, an official order stated on Friday.
Political, social, sporting or religious congregations, protest rallies or processions will remain banned across Noida and Greater Noida during the period, the district police said.
Except for medical personnel and essential service providers, nobody would be allowed to go in or out of containment zones in Gautam Buddh Nagar, the order said. – PTI
9 am | India
Human clinical trial of COVID-19 vaccine ‘Covaxin’ begins at Gorakhpur hospital
The human clinical trial of indigenously developed Covaxin, a possible vaccine against coronavirus, began at a hospital in Gorakhpur, officials said.
The trial began on Thursday evening at Rana Hospital and Trauma Centre, which is among the 12 institutes selected for clinical trials of the vaccine, officials said.
Those who were administered the vaccine have been kept under observation and all of them are “absolutely fine”, said Chief Administrative Officer of the hospital, Venketesh Chaturvedi. – PTI
8.30 am | Economy
The eurozone registers a historic 12.1% collapse in the second quarter, according to Eurostat.
France’s economy slumps a record 13.8% over the period following a strict coronavirus lockdown that slammed consumer spending, the INSEE statistics agency says.
Spain also records an 18.5% plunge in GDP, as a result of one of Europe’s most stringent lockdowns which battered its key tourism industry. Portugal’s economy plunges by 14.1% and Italy’s an unprecedented 12.4%. – AFP
8 am | World
Large U.S. COVID-19 vaccine trials will exclude pregnant women for now
The first two COVID-19 vaccines to enter large-scale U.S. trials will not be tested in pregnant women this year, raising questions about how this vulnerable population will be protected from the coronavirus, researchers told Reuters.
Moderna and Pfizer, which has partnered with Germanys BioNTech , this week separately launched clinical trials that use a new and unproven gene-based technology. Both companies are requiring proof of a negative pregnancy test and a commitment to using birth control from women of childbearing age who enroll. – Reuters